MichaelAnthonyMcDevittMD

Assistant Professor of Medicine, Assistant Professor of Oncology, Johns Hopkins University School of Medicine

Dr. McDevitt is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1992 - 1995
Johns Hopkins UniversityResidency, Internal Medicine, 1989 - 1992
Weill Cornell MedicineClass of 1989

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014

PubMed

29 citations
Phase I study of ABBV-428, a mesothelin-CD40 bispecific, in patients with advanced solid tumors
Jason J. Luke, Fabrice Barlesi, Ki Y. Chung, Anthony W. Tolcher, Karen Kelly
Journal for Immunotherapy of Cancer. 2021-02-01
9 citations
Dynamics of mutations in patients with essential thrombocythemia treated with imetelstat.
Elisabeth Oppliger Leibundgut, Monika Haubitz, Bart Burington, Oliver G. Ottmann, Gary Spitzer
Haematologica. 2020-07-30
12 citations
BRCA1 Promoter Methylation Is Linked to Defective Homologous Recombination Repair and Elevated miR-155 to Disrupt Myeloid Differentiation in Myeloid Malignancies
Weijie Poh, Robert L. Dilley, Alison R. Moliterno, Jaroslaw P. Maciejewski, Keith W. Pratz
Clinical Cancer Research. 2019-04-15

Idaho Pharmacies Prepare for Ages 16+ to Become Eligible for COVID-19 VaccineMarch 26th, 2021
Memorial Medical Center, a State Highly Infectious Disease Facility, Confident in Its Coronavirus PreparednessMarch 12th, 2020